Different Features of Interleukin-37 and Interleukin-18 as Disease Activity Markers of Adult-Onset Still's Disease

被引:12
|
作者
Nam, Seoung Wan [1 ]
Kang, SuMan [2 ]
Lee, Jun Hyeok [3 ]
Yoo, Dae Hyun [2 ,4 ]
机构
[1] Yonsei Univ, Wonju Coll Med, Wonju Severance Christian Hosp, Dept Rheumatol, Wonju 26426, South Korea
[2] Hanyang Univ, Inst Rheumatol Res, Seoul 04763, South Korea
[3] Yonsei Univ, Wonju Coll Med, Dept Biostat, Wonju 26426, South Korea
[4] Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul 04763, South Korea
关键词
interleukin-37; interleukin-18; adult-onset Still’ s disease; BLOOD MONONUCLEAR-CELLS; C-REACTIVE PROTEIN; CYTOKINE PROFILES; CLINICAL-MANIFESTATIONS; INFLAMMATORY CYTOKINES; IL-18; ARTHRITIS; IL-37; BIOMARKER; PATHOGENESIS;
D O I
10.3390/jcm10050910
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to evaluate the usefulness of serum interleukin (IL)-37 and IL-18 as disease activity markers of adult-onset Still's disease (AOSD) and to compare their related clinical features. Forty-five patients with a set of high and subsequent low disease activity status of AOSD were enrolled. Modified Pouchot (mPouchot) score and serologic disease activity markers including levels of IL-37 and IL-18 were compared between high and low disease activity status. The relationships between disease activity parameters and differences in levels of cytokines according to each disease manifestation were evaluated in high disease activity status. mPouchot score and all disease activity markers including IL-37 and IL-18 significantly declined after treatment. Though both cytokines positively correlated with mPouchot score, the two did not correlate with each other in high disease activity status. IL-18 positively correlated with ferritin, AST, and LDH while IL-37 correlated better with CRP. The expression level of IL-37 was related to leukocytosis while IL-18 was related to pleuritis, pneumonitis, abnormal LFT, and hyperferritinemia. In addition, patients in the IL-18 dominant group presented with higher LDH levels and required a higher mean corticosteroid dose. In conclusion, IL-37 and IL-18 are disease activity markers reflecting different aspects of AOSD that can complement each other.
引用
收藏
页码:1 / 14
页数:13
相关论文
共 50 条
  • [31] New Markers for Adult-Onset Still's Disease
    Mitrovic, Stephane
    Fautrel, Bruno
    JOINT BONE SPINE, 2018, 85 (03) : 285 - 293
  • [32] Extremely high levels of interleukin-18 and interleukin-18 binding protein in the blood circulation of patients with adult Still's disease.
    Kawashima, M
    Yamamura, M
    Makino, H
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S80 - S80
  • [33] Association of interleukin 18 polymorphisms with adult onset still's disease in Korea
    Woo, Jin-Hyun
    Seong, Sang-Seokg
    Yoo, Dae-Hyun
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1637 - 1639
  • [34] Interleukin-18 (IL-18) As a Biomarker for Diagnosis and Evaluation of Disease Activity in Patients with Adult Onset Still's Disease and Systemic Onset Juvenile Idiopathic Arthritis.
    Kudela, Holger
    Drynda, Susanne
    Lux, Anke
    Horneff, Gerd
    Kekow, Joern
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S367 - S367
  • [35] Interleukin 6: A possible marker of disease activity in adult onset Still's disease
    Scheinberg, MA
    Chapira, E
    Fernandes, ML
    Hubscher, O
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (06) : 653 - 655
  • [36] Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis
    Koga, Tomohiro
    Sumiyoshi, Remi
    Furukawa, Kaori
    Sato, Shuntaro
    Migita, Kiyoshi
    Shimizu, Toshimasa
    Umeda, Masataka
    Endo, Yushiro
    Fukui, Shoichi
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Origuchi, Tomoki
    Nonaka, Fumiaki
    Yachie, Akihiro
    Kondo, Hideaki
    Maeda, Takahiro
    Kawakami, Atsushi
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [37] Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease
    Chen, DY
    Lan, JL
    Lin, FJ
    Hsieh, TY
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (03): : 320 - 327
  • [38] Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still’s disease from sepsis
    Tomohiro Koga
    Remi Sumiyoshi
    Kaori Furukawa
    Shuntaro Sato
    Kiyoshi Migita
    Toshimasa Shimizu
    Masataka Umeda
    Yushiro Endo
    Shoichi Fukui
    Shin-ya Kawashiri
    Naoki Iwamoto
    Kunihiro Ichinose
    Mami Tamai
    Hideki Nakamura
    Tomoki Origuchi
    Fumiaki Nonaka
    Akihiro Yachie
    Hideaki Kondo
    Takahiro Maeda
    Atsushi Kawakami
    Arthritis Research & Therapy, 22
  • [39] Interleukin-1 Inhibitors and Dacryoadenitis in Adult-Onset Still Disease
    Breillat, Paul
    Tourte, Maylis
    Romero, Pierre
    Hayem, Gilles
    Padovano, Ilaria
    Costantino, Felicie
    Breban, Maxime
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (06) : 455 - +
  • [40] Free Interleukin 18 As a Predictor of Remission and Flare up in Adult-Onset Still's Disease Patients.
    Jung, Kyong-Hee
    Lee, Joo Hyun
    Kim, JinJu
    Lee, Jin Sook
    Park, Won
    Kim, Tae-Hwan
    Yoo, Dae-Hyun
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S764 - S764